FIELD: medicine, oncology.
SUBSTANCE: through a catheter it is necessary to conduct prolonged polychemotherapy due to single regional intra-arterial injection of oxaliplatin at the dosage of 150 mg/sq. m into general hepatic artery as 12-h-long infusion and 5-fluorouracil at the dosage of 1000 mg/sq. m daily in the course of every course due to prolonged 120-h-long infusion. The duration of therapy - 4 courses of infusions at 28-d-long intervals. The innovation provides efficient therapy of the pathology mentioned due to increasing a single and a course dosage of anti-tumor preparations of low toxicity, at no complications that requires no hyperhydration procedures.
EFFECT: higher efficiency of therapy.
1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING PATIENTS SUFFERING FROM COLORECTAL CANCER WITH LIVER METASTASES | 2007 |
|
RU2372089C2 |
METHOD FOR TREATMENT OF COLORECTAL CANCER METASTASIS IN LIVER | 2003 |
|
RU2241459C2 |
METHOD OF COMBINATION THERAPY OF RECTAL CANCER | 2013 |
|
RU2538672C1 |
METHOD OF TREATING INOPERABLE PANCREATIC ADENOCARCINOMA WITH LIVER METASTASES | 2019 |
|
RU2706786C1 |
METHOD OF TREATING INOPERABLE PANCREATIC HEAD ADENOCARCINOMA | 2019 |
|
RU2706341C1 |
CHEMOTHERAPY MODE IN HEPATIC METASTASES OF GASTRIC CARCINOMA | 2008 |
|
RU2364397C1 |
METHOD OF TREATING OPERABLE GASTRIC ADENOCARCINOMA | 2019 |
|
RU2706346C1 |
METHOD OF PERSONALIZED NEOADJUVANT INTRA-ARTERIAL CHEMOTHERAPY OF GASTRIC CANCER | 2021 |
|
RU2797397C2 |
METHOD FOR COMBINED TREATMENT OF METASTATIC COLORECTAL CANCER IN PATIENTS WITH RESECTABLE HEPATIC METASTASES AND IN THE ABSENCE OF MUTATIONS IN THE KRAS AND BRAF GENES | 2021 |
|
RU2764955C1 |
METHOD OF TREATING LOCALLY ADVANCED UNRESECTABLE PANCREATIC CANCER | 2013 |
|
RU2528881C1 |
Authors
Dates
2007-04-20—Published
2005-04-04—Filed